𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Maximizing Human Epidermal Growth Factor Receptor 2 Inhibition: A New Oncologic Paradigm in the Era of Targeted Therapy

✍ Scribed by Olson, E. M.

Book ID
111678244
Publisher
American Society of Clinical Oncology
Year
2012
Tongue
English
Weight
111 KB
Volume
30
Category
Article
ISSN
0732-183X

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Inhibition of growth and induction of en
Inhibition of growth and induction of enzyme activities in a clonal human hepatoma cell line (Li-7A): Comparison of the effects of epidermal growth factor and an anti-epidermal growth factor receptor antibody
✍ Aileen F. Knowles πŸ“‚ Article πŸ“… 1988 πŸ› John Wiley and Sons 🌐 English βš– 780 KB

A cloned human hepatoma cell line (Li-7A), possessing epidermal growth factor (EGF) receptors numbering in the range of 10-20 pmol/106 cells, was inhibited in its growth by EGF as well as an antagonist monoclonal antibody (MoAb) to the EGF receptor. The mode of action of the two ligands of EGF recep

The role of human epidermal growth facto
The role of human epidermal growth factor receptor 2 in the survival of women with estrogen and progesterone receptor-negative, invasive breast cancer: The California Cancer Registry, 1999–2004
✍ Monica Brown; Alex Tsodikov; Katrina R. Bauer; Carol A. Parise; Vincent Caggiano πŸ“‚ Article πŸ“… 2008 πŸ› John Wiley and Sons 🌐 English βš– 207 KB πŸ‘ 2 views

## Abstract ## BACKGROUND Breast cancers that are negative for estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2) (triple negative [TN]) have been associated with high‐grade histology, aggressive clinical behavior, and poor survival. It has been